Acta Neurologica Scandinavica · 2002 · 22 citations · 27 references
MedicineEndocrinologyNeurologyInflammationNeuroendocrinologyNeuroimmunologyAdrenal Axis RegulationHpa AxisInflammatory ProcessesMultiple SclerosisNeuroimmune RegulationNeuroinflammationAdrenal Axis DysregulationHpa Axis FunctionHpa Axis ResponsivityHpa FunctionHypothalamic-pituitary-adrenal Axis RegulationInflammatory Cytokine ProductionPro-inflammatory Mediator ProductionRelapsing-remitting Multiple Sclerosis Treatment
OBJECTIVES: Pro-inflammatory cytokines mediate brain damage in multiple sclerosis (MS); they can also influence the hypothalamic-pituitary-adrenal (HPA) axis function. We evaluated the possible abnormalities of HPA axis function in relapsing-remitting MS (RR-MS). MATERIAL AND METHODS: IFN-gamma, TNF-alpha and IL-6 production by ex-vivo lymphocytes from 10 normal volunteers and 10 RR-MS patients before and during IFN-beta therapy was assessed; pituitary-adrenal function was evaluated by means of CRH and ACTH stimulation tests. RESULTS: In untreated patients the production of IFN-gamma, TNF-alpha, IL-6 was increased, and was significantly decreased by IFN-beta. Neither basal, nor stimulated ACTH, cortisol, DHEA, DHEAs, 17-alpha-OH-progesterone levels differed between controls and RR-MS patients, both before and during treatment. Moreover, no correlation was found between endocrine and immune parameters. CONCLUSION: In MS the HPA axis function seems normal and not influenced by IFN-beta treatment. This result is discussed in relation to the increased production of pro-inflammatory cytokines found in this disease.
27
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
Neurology · 1993 · 2.1K citations
Pharmacy, Neurology, Pharmacotherapy +14
Interleukin-1 Stimulates the Secretion of Hypothalamic Corticotropin-Releasing Factor
Robert M. Sapolsky, Catherine Rivier, Gayle Yamamoto et al. · Science · 1987 · 1.5K citations
Tumor necrosis factor identified in multiple sclerosis brain.
Florence M. Hofman, David R. Hinton, K. P. Johnson et al. · The Journal of Experimental Medicine · 1989 · 799 citations